|
LOC440944 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.362000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.250850E-01 |
| Normal-vs-Stage2 |
1.745980E-01 |
| Normal-vs-Stage3 |
1.250340E-02 |
| Normal-vs-Stage4 |
5.157600E-01 |
| Stage1-vs-Stage2 |
7.317600E-01 |
| Stage1-vs-Stage3 |
1.631190E-01 |
| Stage1-vs-Stage4 |
7.694200E-01 |
| Stage2-vs-Stage3 |
6.380800E-01 |
| Stage2-vs-Stage4 |
6.425200E-01 |
| Stage3-vs-Stage4 |
3.384400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.740300E-02 |
| Normal-vs-AfricanAmerican |
1.024820E-01 |
| Normal-vs-Asian |
6.811000E-01 |
| Caucasian-vs-AfricanAmerican |
7.438800E-01 |
| Caucasian-vs-Asian |
2.684600E-01 |
| AfricanAmerican-vs-Asian |
2.372600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.361600E-01 |
| Normal-vs-Female |
4.671800E-02 |
| Male-vs-Female |
2.376800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.013800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.093240E-01 |
| Normal-vs-Age(61-80Yrs) |
1.174220E-01 |
| Normal-vs-Age(81-100Yrs) |
1.344030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.098400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.201200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.677000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.270200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.574800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.501000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.416500E-04 |
| Classical-VS-Follicular |
5.974600E-01 |
| Classical-VS-Other |
6.966400E-01 |
| Classical-VS-Normal |
1.685240E-01 |
| Tall-VS-Follicular |
2.263900E-02 |
| Tall-VS-Other |
3.271600E-02 |
| Tall-VS-Normal |
4.167000E-04 |
| Follicular-VS-Other |
6.140000E-01 |
| Follicular-VS-Normal |
1.429980E-01 |
| Other-VS-Normal |
9.150800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.124400E-02 |
| Normal-vs-N1 |
4.527600E-01 |
| N0-vs-N1 |
4.324100E-02 |
|
|
